Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein
ACS Omega · 12.09.2023 · 8 (36) · 32729-32739
DOI: 10.1021/acsomega.3c03610 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 28.08.2023. Verfasst von Kristina Niort und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm UMR-S 1266, Institute of Psychiatry and Neuroscience of Paris (IPNP), Paris 75014, France. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche, Institut National de la Sant? et de la Recherche M?dicale, Fondation pour la Recherche M?dicale.
Abstract (Originalsprache)
SARS-CoV-2 entry into host cells is mediated by the Spike (S) protein of the viral envelope. The S protein is composed of two subunits: S1 that induces binding to the host cell via its interaction with the ACE2 receptor of the cell surface and S2 that triggers fusion between viral and cellular membranes. Fusion by S2 depends on its heptad repeat domains that bring membranes close together and its fusion peptide (FP) that interacts with and perturbs the membrane structure to trigger fusion. Recent studies have suggested that cholesterol and ceramide lipids from the cell surface may facilitate SARS-CoV-2 entry into host cells, but their exact mode of action remains unknown. We have used a combination of in vitro liposome-liposome and in situ cell-cell fusion assays to study the lipid determinants of S-mediated membrane fusion. Our findings reveal that both cholesterol and ceramide lipids facilitate fusion, suggesting that targeting these lipids could be effective against SARS-CoV-2. As a proof of concept, we examined the effect of chlorpromazine (CPZ), an antipsychotic drug known to perturb membrane structure. Our results show that CPZ effectively inhibits S-mediated membrane fusion, thereby potentially impeding SARS-CoV-2 entry into the host cell.
Autor:innen und Institutionen
- Université Paris Cité, Inserm UMR-S 1266, Institute of Psychiatry and Neuroscience of Paris (IPNP), Paris 75014, France.
- Université Paris Cité, Inserm U 1316, CNRS UMR 7057, Laboratoire Matières et Systèmes Complexes (MSC), Paris 75006, France.
ORCID-Profile: Grégory Lavieu, David Tareste
Förderung
- Agence Nationale de la Recherche
- Institut National de la Sant? et de la Recherche M?dicale
- Fondation pour la Recherche M?dicale
- Fondation de France
- French Muscular Dystrophy Association
- Universit? Paris Cit?
Zitieren
APA
Niort, K., Dancourt, J., Boedec, E., Al Amir Dache, Z., Lavieu, G., & Tareste, D. (2023). Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein. ACS Omega, 8(36), 32729-32739. https://doi.org/10.1021/acsomega.3c03610
Vancouver
Niort K, Dancourt J, Boedec E, Al Amir Dache Z, Lavieu G, Tareste D. Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein. ACS Omega. 2023;8(36):32729-32739. doi:10.1021/acsomega.3c03610
BibTeX
@article{Niort2023,
author = {Niort, Kristina and Dancourt, Julia and Boedec, Erwan and Al Amir Dache, Zahra and Lavieu, Grégory and Tareste, David},
title = {Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {36},
pages = {32729--32739},
doi = {10.1021/acsomega.3c03610}
}
EUVIMED